Bruker jumps as Q1 revenue and adjusted EPS beat estimates, FY26 outlook reaffirmed
Bruker shares surged after reporting Q1 2026 results that beat Wall Street expectations on both revenue and adjusted EPS. The company posted $823.4 million in revenue (+2.7% YoY) and adjusted EPS of $0.31 versus $0.23 expected while reaffirming full-year guidance.
1. What’s moving the stock
Bruker (BRKR) is rallying after its first-quarter 2026 earnings release topped expectations, triggering a sharp re-rating in early trading. Investors are focusing on the size of the profit surprise and management’s decision to reaffirm full-year targets despite macro and currency headwinds. (markets.financialcontent.com)
2. The numbers that mattered
For Q1 2026 (ended March 31, 2026), Bruker reported revenue of $823.4 million, up 2.7% year over year and above estimates near $796 million. Adjusted (non-GAAP) EPS was $0.31, ahead of the $0.23 consensus, while GAAP EPS was $0.02. (stocktitan.net)
3. Guidance and demand signals
Bruker reaffirmed FY2026 guidance for revenue of $3.57 billion to $3.60 billion and non-GAAP EPS of $2.10 to $2.15. Management highlighted high-single-digit organic bookings growth in Bruker Scientific Instruments and said the segment’s book-to-bill ratio has remained above 1.0x for a third consecutive quarter, pointing to improving demand visibility as the company expects a return to organic revenue growth in Q2. (stocktitan.net)
4. What to watch next
After a large one-day move, attention will shift to whether bookings strength converts into accelerating organic growth in Q2 and whether margin pressures ease through the rest of 2026. Investors will also watch commentary on tariffs, currency impacts, and end-market demand trends such as semiconductor metrology and lab software. (stocktitan.net)